Boston Scientific (NYSE:BSX) released new clinical trial results for its FARAPULSE PFA Platform and WATCHMAN LAAC at Heart ...
Over the last weekend, Chicago played host to the 2026 edition of the Heart Rhythm Society's annual conference (HRS 2026).
Boston Scientific, Abbott and Medtronic shared new cardiac device data at the annual Heart Rhythm Society meeting, where ...
Boston Scientific Corporation (NYSE: BSX) today announced data supporting use of the company's FARAPULSE™ Pulsed Field Ablation (PFA) Platform and WATCHMAN™ Left Atrial Appendage Closure (LAAC) ...
Boston Scientific (NYSE:BSX) today shared new clinical findings supporting its wide-ranging electrophysiology (EP) portfolio.
Protaryx Medical, a Maryland-based company dedicated to “minimally invasive left-heart interventional therapies,” announced that its ...
Boston Scientific Corporation (NYSE: BSX) generated net sales of $5.203 billion during the first quarter of 2026 ...
CEO Mike Mahoney told investors that the lowered forecast reflects challenges for several businesses, including ...
Boston Scientific Corporation secured net sales of $5.203 billion during the first quarter of 2026, growing 11.6% overall.
Boston Scientific Corp. reports first-quarter earnings Wednesday morning, a pivotal moment for investors trying to determine ...
Background The use of artificial chords for mitral valve prolapse during minimally invasive mitral valve repair (MIMVR) has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results